Shubham Aggarwal of Quantsapp Advisory has a sell call on Glenmark Pharmaceuticals Ltd.
with a target price of Rs 304.0 .
The current price of Glenmark Pharmaceuticals Ltd.
is Rs 318.65 Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd.
price can reach defined target.Shubham Aggarwal recommended to keep a stoploss at Rs 330 .
Glenmark Pharmaceuticals Ltd., incorporated in 1977, has a market cap of Rs 8991.29 crore.Glenmark Pharmaceuticals Ltd.
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6042.06 Crore to Sales Value (93.93 % of Total Sales), Other Operating Revenue which contributed Rs 335.83 Crore to Sales Value (5.22 % of Total Sales) and Sale of services which contributed Rs 54.00 Crore to Sales Value (0.83 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 2763.73 Crore, up 21.02 % from last quarter Sales of Rs 2283.60 Crore and up 8.81 % from last year same quarter Sales of Rs 2539.86 Crore Company has reported net profit after tax of Rs 255.54 Crore in latest quarter.
The companys top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto, Ms.Saira Ramasastry.
Company has Walker, Chandiok - Co.LLP as its auditors As on 31-12-2019, the company has a total of 282,168,156 shares outstanding.